The largest database of trusted experimental protocols
> Genes & Molecular Sequences > Nucleotide Sequence > Alternative Splice Sites

Alternative Splice Sites

Alternative Splice Sites refer to the process where a single gene can produce multiple mRNA transcripts by selectively including or excluding different segments of the gene's coding sequence.
This allows for greater protein diversity and functional complexity from a single gene.
Researchers studying Alternative Splice Sites can leverage PubCompare.ai's AI-powered platform to quickly locate the latest protocols, preprints, and patents, and identify the best methods and products through efficent comparissons.
Take your Alternative Splice Sites research to the next level with PubCopare.ai's intuitive tools.

Most cited protocols related to «Alternative Splice Sites»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Alternative Splice Sites Biological Evolution DNA, Complementary Exons Expressed Sequence Tags Gene Annotation Genome Introns Retention (Psychology) RNA-Seq Splice Acceptor Site Tissue Donors
CLIP tags and clusters were analyzed with BED or WIG formatted custom tracks using the UCSC Genome Browser and Genome Graph tools (genome.ucsc.edu). Composite maps were generated by determining the distance between tags and closest splice sites within the alternative exon local region and converted to coordinates in a BED format custom track, with tags from each gene assigned different colors. MEME sequence analysis was done using tools available at meme.sdsc.edu. ASPIRE2 was based on ASPIRE20 (link).
Publication 2008
Alternative Splice Sites Clip Exons Genes Genome Microtubule-Associated Proteins Sequence Analysis
For the simulation we used the quantification of RefSeq transcripts for the three control samples from [17 (link)] (GSE59335) with Salmon [31 ] as theoretical abundances, and considered genes with only two isoforms containing a skipping exon (SE) or alternative splice site (A5/A3) event and only one associated event. For the benchmarking analysis, we selected a set of positive and a set of negative events for each event type with the same number of randomly chosen events, 277 for SE events and 318 for A5/A3 events. For the positive set we simulated differential splicing by exchanging the theoretical abundance of their associated transcript values. We selected to be positive events only those having an absolute difference of relative abundance greater than 0.2, so that the simulated change was sufficiently large: TPM1TPM2TPM1+TPM2>0.2
where TPM1 and TPM2 are the abundances for the two transcripts in the gene, given in TPM units. For the negative set, we took an equal number of events without exchanging their TPM values. These negative events had a gene expression distribution and a distribution of transcript relative abundance similar to the positive events, and an expected variability between conditions similar to the variability between biological replicates. We used RSEM [39 (link)] to simulate sequencing reads for the two conditions, three replicates each, at various depths (120, 60, 25, 10 and 5 M 100-nt paired-end reads per sample) and at various read lengths (100, 75, 50, and 25 nt, at a depth of 25 M paired-end reads) (Additional file 2: Tables S1–S3). Further details of the simulations are given in the Additional file 3:Supplementary material. Datasets and commands to reproduce these simulations are available at https://github.com/comprna/SUPPA_supplementary_data.
Publication 2018
Alternative Splice Sites Biopharmaceuticals Exons Gene Expression Genes Protein Isoforms Salmo salar
In this study, the known/model splice junctions (SJs) was defined by joining splice sites at the exon-intron boundaries of all annotated introns in the recently published genome [28 (link)], generating a total of 19,150 such model/known SJs. All other SJs involving only one or none of the known splice site were considered as novel junction. SJs in the transcriptome of V. dahliae supported by cDNA reads were identified using TopHat tool [40 (link)]. Junction reads were required to have at least 8-nt mapped on each of the adjacent exons. The junctions located inside of the coordinates of annotated genes were regarded as genic SJs. All the genic SJs were classified into one of the nine types of AS events. Seven of canonical AS events were skipped exons (ES), cassette exon (CE), alternative 5′-splice sites (A5SS), alternative 3′-splice sites (A3SS), mutually exclusive exons (MXE), alternative first exons (AFE or 5′ MXE) and alternative last exons (ALE or 3′ MXE), according to the models described previously [6 (link)]. Algorithm aJAS is based on a given gene model and calculates sequence reads supporting each distinct composite SJs associated with a specific novel SJ. The novel SJs containing at least two support reads were selected for analysis. To be a qualified candidate aJAS event, the ratio of reads supporting the novel/alternative SJs to the total was at least 15%.
Retained intron or intron retention (RI or IR) is caused by reduced usage of the candidate splice sites, which cannot be predicted effectively by considering splice junctions. This class of alternative splicing event was identified according to the border reads spanning exon-intron junction and the mean of local reads depth. Four criteria have to be met to be considered as a RI event. (1) The mean base depth in the candidate intron is at least 20% of the flanking exon; (2) The sum of the intronic depth is greater than 100; (3) border reads at either the 5′ or 3′ splice site of the candidate must be present; (4) no other type of AS event could be identified.
Publication 2017
Alternative Splice Sites DNA, Complementary Exons Genes Genome Introns Retention (Psychology) Splice Acceptor Site Transcriptome
CLIP tags and clusters were analyzed with BED or WIG formatted custom tracks using the UCSC Genome Browser and Genome Graph tools (genome.ucsc.edu). Composite maps were generated by determining the distance between tags and closest splice sites within the alternative exon local region and converted to coordinates in a BED format custom track, with tags from each gene assigned different colors. MEME sequence analysis was done using tools available at meme.sdsc.edu. ASPIRE2 was based on ASPIRE20 (link).
Publication 2008
Alternative Splice Sites Clip Exons Genes Genome Microtubule-Associated Proteins Sequence Analysis

Most recents protocols related to «Alternative Splice Sites»

To detect alternative mRNA associations with AUD we used Leafcutter version 0.2.923 (link). Leafcutter is a powerful transcriptome-wide splicing method that uses a Dirichlet-multinomial generalized linear regression to identify differentially spliced genes. A differentially spliced gene generally is composed of multiple clusters, each of which includes various alternative splicing events, such as exon-skipping (see Fig. 1), intron retention, alternative acceptor or alternative donor splice sites, which we annotated with the Vertebrate Alternative Splicing and Transcription Database (https://vastdb.crg.eu/wiki/Main_Page). Each splicing event corresponds to a change in percent spliced in (ΔPSI or dPSI) metric. In our AUD analyses, a positive ΔPSI for an exon skipping event would suggest that an individual with AUD is more likely to skip a certain exon than someone without AUD. We utilized the default filtering parameters of Leafcutter that filtered out splicing clusters with < 5 samplers per intron, < 3 samples per group, and required at least 20 reads, which resulted in 18,685 unique genes across human brain regions. Human differential splicing analyses covaried for sex, age, brain pH, PMI, and smoking status. Note leafcutter performs analyses at the cluster level calculating a cluster p-value and then performs a Benjamini–Hochberg False Discovery (BH-FDR) multiple testing correction. Differentially spliced genes/clusters were those that survived a standard BH-FDR adjusted p-value < 0.05. We corrected p-values for multiple testing within brain regions and thus, our analyses do not account for multiple testing across tissues or samples. Since only 21 genes were differentially spliced in primates (BH-FDR < 0.05), we defined significant differential splicing with a nominal p-value threshold < 0.05. When possible, primate differential splicing analyses controlled for age (NAc sample). We assessed linear correlations of the ΔPSI across all significant alternative splicing events that were common across brain regions.
To assess the overlap between human and primate results we used a Fisher’s Exact test at the gene-level and restricted analyses to homologous genes identified by biomaRt24 (link) and only used results from analogous regions of the brain (CEA, NAc, and PFC). In humans, we compared our differential splicing analyses with differentially expressed genes. Differential expression analyses leveraged featureCounts to count aligned RNA-seq reads and used DESeq225 (link) to determine differential expression. Differential expression analyses used the same covariates and p-value adjustment as differential splicing analyses. Previous differential splicing analyses of these data7 (link) used rMATS26 (link) that focuses on individual splicing events (rather than broader clusters within genes) and leverages a joint likelihood function combining binomial and normal distributions.
Publication 2023
Alternative Splice Sites Brain Exons Gene Clusters Genes Genetic Testing Homo sapiens Introns Joints Primates Retention (Psychology) RNA, Messenger RNA-Seq Tissue Donors Tissues Transcription, Genetic Transcriptome Vertebrates
We used rMATS (https://rnaseq-mats.sourceforge.net/index.html) to detect and analyze alternative splicing events, including skipped exon, alternative 5′ splice site (A5SS), alternative 3′ splice site (A3SS), mutually exclusive exons (MXE), and retained intron (RI).
Publication 2023
Alternative Splice Sites Exons Introns

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Alternative Splice Sites Cells Cisplatin Exons Introns Retention (Psychology)
Genomic DNA was extracted from the saliva of 10 patients and their available family members according to the prepIT® L2P protocol for the purification of genomic DNA using the Oragene® collection kit (DNA Genotek Inc., Ottawa, ON, Canada). Eight DNA samples from two affected patients (patients 1 and 2), four unaffected siblings, and their parents in family 1 were targeted for a whole-exome sequencing (WES) (Marcogen Inc., Seoul, Korea) protocol to detect variants in protein-coding genes.
Exon capture was performed using the SureSelect target Enrichment system (Agilent, Santa Clara, CA, USA), and then pair-end sequencing was conducted on a HiSeq 2000/2500 sequencing machine. The Burrows-Wheeler Alignment tool (BWA-0.7.17) was used to align the 100 bp paired-end reads from the sequencer with the human reference genome assembly (hg19 from UCSC; GRCh37 from NCBI). Single-nucleotide variants (SNVs) and small INDEL variants were identified by Picard (picard-tool-2.9.0), Genome analysis toolkit (GATKv3.8.1), and Ensembl VEP (VEP bulid 105). Mutation discovery was based on the use of variants called from the WES of eight members of family 1. Bidirectional direct sequencing (Functional Biosciences, Madison, Wisconsin, USA) was carried out with DNA from all eight family members: two affected (II-3 and II-5) and four unaffected siblings (II-1, II-2, II-4, II-6) and their unaffected parents (I-1 and I-2). Sequencher 4.8 Sequence analysis software (Genecodes, Ann Arbor, MI, USA) was used to analyze the presence of variants and co-segregation between genotypes and phenotypes within family 1. Bioinformatic predictions of the variant impact were performed using MutationTaster (https://www.mutationtaster.org, accessed on 8 January 2023), PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2, accessed on 8 January 2023), and SIFT (https://sift.bii.a-star.edu.sg/, accessed on 8 January 2023). Once the variant was identified in family 1, bidirectional direct Sanger sequencing of P3H1 was performed with DNA from all 10 patients and their available family members (Figure 1 and Figure 8).
To investigate the possible effects of the variant on splicing, the contiguous sequence representing the last two exons and the final intron of P3H1 were submitted as both the reference sequence format and the variant format to Alternative Splice Site Prediction (ASSP) [13 (link)].
Publication 2023
Alternative Splice Sites Exons Family Member Genes Genome Genome, Human Genotype INDEL Mutation Introns Mutant Proteins Mutation Nucleotides Parent Patients Phenotype Saliva Sibling
Genomic DNA was extracted from the peripheral blood samples of the participants. DNA libraries were constructed using the SureSelect Human All Exon V6 kit (Agilent Technologies) and sequenced on NovaSeq or HiSeq sequencers (Illumina). VCF files were created using DRAGEN (version 3.9.5; Illumina). The sequence reads were mapped to the human reference genome (GRCh37/hg19 with decoy sequences [hs37d5]).
Exome data of the patients and control individuals were subjected to SKAT‐O using the SNP and Variation Suite (version 8.4.1; Golden Helix). We focused on protein‐altering variants (missense and nonsense variants, indels, and splice‐site substitutions), whose allele frequency in the ToMMo database (version 8.3KJPN; https://www.megabank.tohoku.ac.jp/) was less than 5%.25 All missense variants underwent in silico functional assessment; we selected variants that were assessed as damaging by three or more of the six programs in dbNSFP (version 3.0, http://database.liulab.science/dbNSFP/).
SKAT‐O was carried out using the very‐small‐sample algorithm with the rho = 1 setting. We searched for genes whose rare variants were more commonly present in the patient group than in the control group. In addition, we examined whether rare variants of known PCOS‐related genes accumulated in the patient group. Bonferroni‐corrected p‐values of <0.05 were considered statistically significant.
The effects of identified variants on protein function and structure were assessed using the combined annotation‐dependent depletion program (CADD; https://cadd.gs.washington.edu/snv) and PyMOL (version 2.5, https://pymol.org/2/), respectively. CADD scores of ≥20 were assessed as probably damaging.26 The protein IDs were obtained from the protein data bank (https://www.rcsb.org/). The effects of the variants on splice‐site recognition were analyzed with Human Splicing Finder (https://hsf.genomnis.com/home), Alternative Splice‐Site Predictor (http://wangcomputing.com/assp/), and NNSPLICE (http://fruitfly.org/seq_tools/splice.html), and the effects on the protein stability were predicted using I Mutant Suite (http://gpcr2.biocomp.unibo.it/cgi/predictors/I‐Mutant3.0/I‐Mutant3.0.cgi). In addition, the hydrophobicity of wildtype and variant GSTO2 proteins was assessed by using ProtScale (https://web.expasy.org/protscale/) with the Kyte and Doolittle model.27 The formation of intrinsically disordered regions, a region without fixed 3‐dimensional structures,28 was predicted by the Predictor of natural disordered regions (PONDR; http://www.pondr.com/) using the VL‐XT method.29
Publication 2023
Alternative Splice Sites BLOOD DNA Library Drosophila Exome Exons Genes Genetic Diversity Genome Genome, Human Helix (Snails) Homo sapiens INDEL Mutation Missense Mutation Mutant Proteins Mutation, Nonsense Patients Polycystic Ovary Syndrome Proteins

Top products related to «Alternative Splice Sites»

Sourced in Germany, United States, Netherlands, United Kingdom, Japan, Canada, France, Spain, China, Italy, India, Switzerland, Austria, Lithuania, Sweden, Australia
The QIAquick Gel Extraction Kit is a product designed for the purification of DNA fragments from agarose gels. It efficiently extracts and purifies DNA from gel slices after electrophoresis.
Sourced in United States, Germany, United Kingdom, Japan, Australia, Canada, China, France, Spain, Netherlands, Lithuania, Switzerland, Belgium, Italy
Superscript III is a reverse transcriptase enzyme produced by Thermo Fisher Scientific. It is designed for cDNA synthesis from RNA templates during the process of reverse transcription.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
The SsoAdvanced master mix is a ready-to-use solution for real-time PCR amplification. It contains a proprietary DNA polymerase, optimized buffer, and dNTPs for efficient and reliable PCR performance.
Sourced in United States
The NEBNext Ultra II RNA Library Prep Kit is a laboratory equipment product designed for the preparation of RNA libraries for next-generation sequencing. It provides a streamlined workflow for converting RNA samples into cDNA libraries compatible with Illumina sequencing platforms.
Sourced in United States, Germany, Japan, United Kingdom
The PCR2.1-TOPO is a cloning vector designed for the direct cloning of Taq polymerase-amplified PCR products. It provides a quick and efficient method for the cloning of PCR fragments without the need for restrictive enzyme digestion or ligation.
Sourced in United States
The HiSeq 1000 is a high-throughput DNA sequencing system developed by Illumina. It is designed to generate large volumes of sequence data efficiently. The HiSeq 1000 uses Illumina's proprietary sequencing-by-synthesis technology to perform massively parallel DNA sequencing. The system is capable of producing up to 600 gigabases of sequence data per run.
Sourced in China
The FastPure Gel DNA Extraction Mini Kit is a tool designed for the rapid and efficient extraction of DNA fragments from agarose gels. The kit utilizes a silica-based membrane technology to selectively bind DNA, allowing for the purification of DNA samples from gel electrophoresis.
RNATri is a laboratory equipment designed for the isolation and purification of RNA from various biological samples. It utilizes a specialized extraction method to effectively separate RNA from other cellular components.

More about "Alternative Splice Sites"

Alternative Splice Sites, also known as Differential Splicing or Splice Variants, refer to the process where a single gene can produce multiple mRNA transcripts by selectively including or excluding different segments of the gene's coding sequence.
This allows for greater protein diversity and functional complexity from a single gene.
Researchers studying Alternative Splice Sites can utilize various techniques and tools to analyze and understand this phenomenon.
One commonly used method is the QIAquick Gel Extraction Kit, which can be used to purify DNA fragments from agarose gels, including those derived from alternative splicing experiments.
The Superscript III reverse transcriptase and TRIzol reagent can be employed to extract and convert RNA into cDNA for downstream analysis.
Lipofectamine 2000 is a transfection reagent that can be used to introduce plasmids or other genetic materials into cells, which can be useful for studying the functional impacts of different splice variants.
In the analysis stage, researchers may utilize the SsoAdvanced master mix for quantitative PCR (qPCR) to measure the expression levels of specific splice variants.
The NEBNext Ultra II RNA Library Prep Kit can be employed to prepare RNA-seq libraries, allowing for the identification and quantification of alternative splice sites.
The PCR2.1-TOPO cloning vector can be used to clone and sequence individual splice variants for further investigation.
For high-throughput sequencing, the HiSeq 1000 sequencer is a powerful tool that can generate vast amounts of sequencing data, enabling researchers to uncover novel splice variants and their expression patterns.
The FastPure Gel DNA Extraction Mini Kit can be used to purify DNA fragments from agarose gels, including those derived from alternative splicing experiments.
Finally, the RNATri reagent can be used to extract high-quality RNA from cells or tissues, which is essential for studying alternative splice sites and their expression profiles.
By leveraging these tools and techniques, researchers can gain deeper insights into the complex world of Alternative Splice Sites and advance their understanding of gene expression and protein diversity.